Abstract
The aim of this work was to assess the association between continuous glucose monitoring (CGM) data, HbA1c, insulin-dose-adjusted HbA1c (IDAA1c) and C-peptide responses during the first 2 years following diagnosis of type 1 diabetes. A secondary analysis was conducted of data collected from a randomised trial assessing the effect of intensive management initiated within 1 week of diagnosis of type 1 diabetes, in which mixed-meal tolerance tests were performed at baseline and at eight additional time points through 24 months. CGM data were collected at each visit. Among 67 study participants (mean age [± SD] 13.3 ± 5.7 years), HbA1c was inversely correlated with C-peptide at each time point (p < 0.001), as were changes in each measure between time points (p < 0.001). However, C-peptide at one visit did not predict the change in HbA1c at the next visit and vice versa. Higher C-peptide levels correlated with increased proportion of CGM glucose values between 3.9 and 7.8 mmol/l and lower CV (p = 0.001 and p = 0.02, respectively) but not with CGM glucose levels <3.9 mmol/l. Virtually all participants with IDAA1c < 9 retained substantial insulin secretion but when evaluated together with CGM, time in the range of 3.9-7.8 mmol/l and C...Continue Reading
References
Jan 1, 1991·Diabetes Research and Clinical Practice·J J CouperL C Harrison
Jul 1, 1987·Diabetologia·E B SochettR M Ehrlich
Jun 10, 1998·Annals of Internal Medicine
Mar 1, 2003·Diabetes Care·Michael W SteffesWilliam Thomas
Jan 29, 2005·Diabetes Care·Edmond A RyanA M James Shapiro
Jun 28, 2006·Diabetes Technology & Therapeutics·UNKNOWN Diabetes Research In Children Network (Direcnet) Study GroupWilliam V Tamborlane
Nov 30, 2006·Diabetes·Garry M SteilMohammed F Saad
Feb 7, 2008·Diabetes Care·Stuart A WeinzimerWilliam V Tamborlane
Jul 17, 2008·Diabetes Care·Carla J GreenbaumUNKNOWN European C-Peptide Trial Study Group
May 14, 2009·Diabetes Care·Henrik B MortensenUNKNOWN Hvidoere Study Group on Childhood Diabetes
Feb 20, 2010·Journal of Diabetes Science and Technology·Jessica R Castle, W Kenneth Ward
Jul 5, 2011·Journal of Diabetes Science and Technology·Kristen L HeltonNatalie A Wisniewski
Dec 14, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·W K WardJ R Castle
Feb 11, 2012·Diabetes Care·Jennifer SherrUNKNOWN Diabetes Research in Children Network (DirecNet) Study Group
Sep 22, 2012·The Journal of Clinical Endocrinology and Metabolism·Marie-Christine VantyghemFrancois Pattou
Jan 10, 2013·Diabetes Technology & Therapeutics·Roy W BeckCraig Kollman
Jun 4, 2013·Diabetes Technology & Therapeutics·Peter CalhounCraig Kollman
Oct 17, 2013·Diabetes Care·Bruce BuckinghamUNKNOWN Type 1 Diabetes TrialNet Study Group
Citations
May 16, 2015·Diabetes Technology & Therapeutics·Eric Renard
Apr 1, 1997·The American Journal of Medicine·R C DetranoR Shavelle
Jul 9, 2016·Expert Review of Molecular Diagnostics·Johnny Ludvigsson
Feb 9, 2018·Pediatric Diabetes·Rebecka EnanderRagnar Hanas
Dec 9, 2017·Frontiers in Endocrinology·Jaquellyne G Penaforte-SaboiaMaria Carolina Oliveira
Feb 27, 2018·Diabetologia·Krishnarajah NirantharakumarParth Narendran
Jan 28, 2020·Diabetes, Obesity & Metabolism·Vit NeumanZdenek Sumnik
Aug 5, 2020·Diabetes Care·Guy S TaylorDaniel J West
Mar 24, 2018·Journal of Diabetes Research·Nina NielensPhilippe A Lysy
Feb 9, 2020·Diabetologia·Fraser W GibbMark W J Strachan
Oct 18, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·D TatovicUNKNOWN MonoPepT1De Study Group
Oct 7, 2017·Diabetologia·Suzy V HopeAngus G Jones
Aug 2, 2020·International Journal of Epidemiology·Louise A C MillardDebbie A Lawlor
Dec 6, 2019·Frontiers in Endocrinology·Jaquellyne Gurgel Penaforte-SaboiaRenan Magalhães Montenegro
Feb 3, 2021·The Journal of Clinical Investigation·Anna LamKevan C Herold
Jun 4, 2021·JMIR Diabetes·Mary Katherine RayTamara Hershey
Aug 12, 2021·Journal of the Endocrine Society·Alice L J CarrRobert C Andrews
Aug 15, 2021·The Journal of Clinical Endocrinology and Metabolism·Yan ChenZhiguang Zhou
Oct 23, 2021·Diabetic Medicine : a Journal of the British Diabetic Association·Parth NarendranDavid J Moore